Medications

Omicron may sideline two leading drugs against COVID-19

As strained U.S. hospitals brace for a new surge of COVID-19 cases caused by the fast-spreading omicron variant, doctors are warning of yet another challenge: the two standard drugs they've used to fight infections are unlikely ...

Medications

New monoclonal antibody shows promise for severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health ...

Immunology

Scientists discover a highly potent antibody against SARS-CoV-2

Scientists at Lausanne University Hospital (CHUV) and EPFL have discovered a highly potent monoclonal antibody that targets the SARS-CoV-2 spike protein and is effective at neutralizing all variants of concern identified ...

Biomedical technology

Drug delivery capsule could replace injections for protein drugs

In recent years, scientists have developed monoclonal antibodies—proteins that mimic the body's own immune defenses—that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn's ...

page 9 from 40